* Phase I trial (QSC205599)

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  1004854

• Contact name

  Lynn Purkins

• Contact email

  lpurkins@reneopharma.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Eudract number

  2021-006892-41

• ISRCTN Number

  ISRCTN57533271

• Research summary

  Publication of this data is currently deferred.

• REC name

  London - Chelsea Research Ethics Committee

• REC reference

  22/FT/0065

• Date of REC Opinion

  13 Jun 2022

• REC opinion

  Further Information Favourable Opinion